Today at AMUG 2019, Dyndrite Corporation announced the launch of its Developer Program and inaugural members of its Developer Council - a select group of industry leaders committed to advancing...

At the American Association for Cancer Research (AACR) Annual Meeting 2019 (March 29 to April 3 in Atlanta, GA) ATCC, a global leader in biological materials/information development, will present...

Cyteir Therapeutics, a leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases,...

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer....

Stand Up To Cancer (SU2C) is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia...